Fifth SENS Conference

August 31 to September 4, 2011 I attended fifth biannual SENS Conference (SENS5, Strategies for Engineered Negligible Senescence) at Cambridge University in the United Kingdom.

People who attend SENS conferences are the demographic that is the most receptive to cryonics of any identifiable group I have yet found. They are mostly scientists interested in intervening in the aging process. Quite a number of attendees are already cryonicists, including Aubrey de Grey, the originator of SENS and the organizer of the conference. But cryonicists are nonetheless a distinct minority. In previous years I brought a few Cryonics Institute brochures, which were soon taken. This year I brought enough brochures for as many of the 240 attendees as might want one (there were many left over).  I also brought a few copies of my “Scientific Justification of Cryonics Practice” (the published write-up of my SENS3 cryonics presentation) which I gave to a few attendees who seemed most receptive.

In addition to my oral presentation on cryonics I also had a poster. Scientific conferences usually have poster sessions where scientists present research, reviews, or ideas in the form of a poster. Poster presenters stand by their posters at scheduled times to discuss their work on a one-to-one basis with individuals rather than to an audience. My poster dealt with challenging the concept of biological age and denying the possibility of a biomarker of aging that could determine biological age. I contended that biological age and biomarkers of aging assume a singular underlying aging process, which I denied on the grounds that aging is multiple forms of damage. I sought to make maximum use of the one-to-one interaction by preparing Socratic questions to stimulate thinking and discussion with the attendees. The process also gave me another means of meeting and speaking to those attending. One interesting person I met was a Torontonian who is currently studying for his PhD at University of Glasgow. His work involves developing gene vectors that can precisely target and modify genes on chromosomes. I consider gene therapy to be an essential tool for the ultimate implementation of SENS, and a deficiency of SENS that there is so little attention paid to this technology. I don’t see how SENS can be implemented by any means other than genetic re-programming. LysoSENS, for example, would require new genes to create new, more effective enzymes for the lysosomes. MitoSENS would require all mitochondrial proteins be made in the nucleus and imported into the mitochondria.

Partly in this connection, was my aggressive lobbying of Aubrey de Grey to have Argentinian biogerontologist and Cryonics Institute member Rodolfo Goya as an invited speaker at SENS5. I began lobbying in January when Dr. de Grey was at ConFusion 2011. Aubrey was initially reluctant based on the first batch of Dr. Goya’s papers that I sent, but a later batch in which Dr. Goya was principle investigator proved to be effective. In Dr. Goya’s presentation at SENS5 he described his use of viral vectors attached to magnetic nanoparticles to deliver IGF-1 genes to senescent female rats to rejuvenate dopamine-producing cells in the hypothalamus. He injects the particles into the venticles, so the technique is somewhat invasive. Another speaker, Matthew Wood, described exosome nanoparticles which can cross the blood-brain barrier so I am hopeful that Dr. Goya can adopt this technique. Dr. Goya ended his presentation with a short pitch for cryonics (showing CI’s cryostats), which even I found embarrassingly awkward. I introduced Dr. Goya to a number of other cryonicists attending SENS5, including Igor Artyuhov, who is the scientific advisor for KrioRus, and Alcor Member Maria Entraigues, who is the SENS volunteer co-ordinator, and a native of Argentina (now living in Los Angeles).

Russian biogerontologist Alexey Moskalev reported on decreasing the number of single-strand DNA breaks and increasing the maximum lifespan in fruit flies by overexpressing the stress response/DNA repair gene GADD45 in the nervous system. That such a presentation would be included in SENS5 was of special interest to me insofar as I have contended that (and debated with Aubrey de Grey concerning) nuclear DNA damage possibly being a significant cause of aging damage that is missing from SENS:

http://www.benbest.com/lifeext/Nuclear_DNA_in_Aging.pdf

http://www.alcor.org/magazine/2011/02/28/deficiencies-in-the-sens-approach-to-rejuvenation/

http://www.alcor.org/magazine/2011/06/07/sens-a-reply-to-ben-best/

Alexey later told me that he had read my paper in REJUVENATION RESEARCH, and I’d like to think that I helped inspire his work.

Alexey announced that there will be a genetics of aging conference in Moscow in April 2012. I entertained the thought of going, partly because of my desire to see KrioRus, but I would rather go later when KrioRus is established in its new building, and has a research program in full swing.

Alexey’s research was partly funded by the Science for Life Foundation (the organization of the wealthy life-extensionist Russian Mikhail Batin). Maria Konovalenko (who was featured in LONG LIFE magazine) reported on her work at the Science for Life Foundation to build an open web-based database of age-related changes (molecular and phenotypic). Maria has her own blog.

I am not going to attempt to describe the other very excellent SENS5 presentations other than to say that great progress has been made in starting research programs on each of the SENS strategies, and by 2012 research on all the strategies is expected to be in progress.

Alcor President Max More was an invited speaker, which means that he had a half-hour time-slot immediately preceding my 15-minute time-slot near the end of the program. Max gave an overview of cryonics, whereas I concentrated on technical and scientific issues associated with vascular and neuronal injury from ischemia and reperfusion. During the question period I was asked if we are interacting with hospital staff to limit pre-mortem ischemia in cryonics patients. I said that the current legal environment limits such interactions, but that pre-mortem anti-oxidant protocol has been recommended and used.

I arranged to send more information to a few people in the audience, including a man who was interested in hydrogen sulfide to limit ischemic injury in cryonics, and an Italian neuroscientist who is interested in neurophysiology studies of vitrified brain tissue as well as contact information for Italian cryonicists.

At the final banquet I sat with CI Member Dr. Gunther Kletetschka, who is now living in the Czech Republic and is pursuing a number of imaginative cryonics-related research projects. One of these involves carbon nanotubes to deliver non-toxic metals to cells to use magnetocaloric cooling. Such a technique could cool tissues uniformly rather than externally, thereby eliminate the thermal stress that causes cracking when vitrified cryonics patients are cooled at cryogenic temperatures.

The last day was spent punting on the Cam River, with dinner in the evening. This provided an opportunity for more networking and information exchange, although most of this was in connection with biogerontology.

There was much biogerontology to be learned at SENS5. What I learned at SENS5 can potentially extend my life and that of others. To postpone cryopreservation by life extension is to benefit from technical advances, to extend the time in which I can contribute to technical advancement, and to enjoy more present life. In the best case, rejuvenation will become a reality in my lifetime and I won’t need to be cryopreserved at all. I work for this possibility as well as for improved cryopreservation. Moreover, in doing research for my cryonics presentation at SENS5 — and in giving the presentation — I learned many things that can help me make more informed choices in directing the research that Aschwin and Chana de Wolf do for the Cryonics Institute.

A video of my presentation may eventually be placed on the SENS5 YouTube site.

Cryonics Oregon june meeting report

About 35 people attended the Cryonics Oregon-sponsored debate on the subject of SENS. Chana Phaedra was mistress of ceremonies. A show of hands indicated that the great majority of those attending were signed-up cryonicists. There was a sizeable contingent of CI Members who drove down from Seattle for the event. One was Eron Hennessey who bid $100 for an autographed Nanomedicine book by Robert Freitas that was auctioned for the benefit of James Swayze (who also attended the event). The money will be kept by Cryonics Oregon to help pay for equipment  for James. Jordan Sparks has offered to build a portable  ice bath that is large enough for James.

About five people came to the event who were non-cryonicists attending the American Aging Association conference, three of whom I brought in a taxi. A biogerontologist cryobiologist who wishes not to be named also attended.

Dr. de Grey began the debate with his standard presentation explaining the SENS program. After I presented my critique, the cryobiologist took the stage and gave his critique of SENS. Aubrey started by answering the cryobiologist, although he commented on a couple of my points. He and the cryobiologist were soon in an active exchange which went on for a while. It became evident to me the Aubrey was not going to get  around to answering my critique in the remaining 15 minutes of the 2-hour booking for the room. I interrupted Aubrey and the cryobiologist suggesting that questions should  be taken from the floor. Aschwin de Wolf added his critique to the debate, and he was followed by others.

There was not much time for socializing, but there was enough for most of us to have a few brief and rewarding conversations with people we had not seen for a while as well as others we were meeting for the first time.  A few Alcor and CI brochures were taken. One man with a CI brochure expressed interest in having cryonics  arrangements with both CI and Alcor. I told him that CI allows those with dual arrangements to have CI as a backup service provider. Alcor allows dual arrangements, but always insists that Alcor be the primary service provider, and that Alcor can never be the backup.

Cryonics Oregon June Meeting with Aubrey de Grey and Ben Best

On June 6th the next Cryonics Oregon meeting will coincide with a downtown Portland aging conference. As a result we have been successful in persuading Cryonics Institute President Ben Best and Alcor member and biogerontologist Aubrey de Grey to attend our meeting. The theme of the evening will be “Strategies for Life extension and Rejuvenation: A Discussion with Aubrey de Grey and Ben Best.”

Dr. Aubrey de Grey will present a brief synopsis of his Strategies for Engineered Negligible Senescence (SENS) for regeneration and rejuvenation. Ben Best will reply with his view of shortcomings of the SENS approach, and how these shortcomings can be addressed. Discussion will include such matters as biomarkers of aging, mechanisms of aging, use of dietary supplements and the relevance of cryonics.

Date:  Sunday, June 6, 2010
Time: 7:30pm – 10:00pm
Location: Roots Organic Brewing
Address: 1520 SE 7TH, Portland, OR

This will be no ordinary Cryonics Oregon meeting! Promotional materials from Alcor, CI, and SENS will be there as well.

To cover the rent of the space a minimum donation of $5.00 per person will be collected.

Attendees under 21 are allowed until 10:00 pm.

It is very important for everyone to RSVP as soon as you know if you can make it or not so we can get a good idea of attendance.

The 2009 SENS Conference

Once a year I try to attend at least one biogerontology conference. Although I attend biogerontology conferences out of personal interest, and at my own expense, they are the most fruitful grounds for promoting cryonics I have found, and this is especially true of SENS conferences.

I have missed none of the four SENS conferences that have been held at Cambridge University. “SENS” is Dr. Aubrey de Grey’s “Strategies for Engineered Negligible Senescence.”

SENS conferences attract scientists who are eager for science to achieve rejuvenation, and who have a strong belief that science has the capacity to do so. Not surprisingly, such people are often receptive to the idea that future science may be capable of reanimating humans who have been well cryopreserved.

Recently I have heard regret expressed about the aging of the cryonics community and the absence of a next generation of cryonics activists to replace the current ones. My experiences at the 2009 SENS conference dispelled much of my concern about this.

I took about a hundred CI brochures, but these were quickly taken by the 290 SENS conference attendees. I was continually approached by young scientists and researchers who were eager to meet me and who said they would make cryonics arrangements when they got out of graduate school and could afford to do so. Insofar as many of the attendees were Europeans, I was often asked whether the shipping delays to the United States would make cryonics not worth doing, and whether there were any plans by the Cryonics Institute to create a storage facility in Europe. (I was told about a group wanting to establish a storage facility in Switzerland, but I did not get any details. Apparently it is not a project with serious hope of success in the near future.)

I was astounded when a British student approached me and said that he would be devoting all of his graduate school work to the problem of cryoprotectant toxicity. He had already gotten Dr. Fahy to send him a copy of “Cryoprotectant toxicity neutralization,” a new paper to be published in an upcoming issue of CRYOBIOLOGY. The student is in the process of collecting other cryobiology publications that address the subject. I directed him to a relevant webpage in the cryonics section of my www.benbest.com website.

A number of people from KrioRus were at the conference, notably Igor Artyuhov, who is their technical guru. The group also does life extension research. Igor showed me their poster showing extended lifespan of mice administered heat-shock protein through nose-drops. I was interviewed by a journalist who writes for the Russian edition of SCIENTIFIC AMERICAN.

I had met Nick Mayer, a Terasem employee, at the previous SENS conference, and Nick introduced himself to me again at this meeting. Nick manages “cyberbiological systems”, specifically a website that is being used like an on-line personal diary. As Nick described it to me, the website would be useful to store personal information that could be used to help in the reconstruction of someone who has been reanimated from cryopreservation. But when I looked at his website, it appears to be a project for reconstructing people from their diaries alone — without any saved biological material.

To my surprise, one of the presenters, Dr. Gunther Kletetschka, had a poster and an oral presentation dealing with eliminating the cracking problem in cryonics.

Cracking of vitrified tissue at cryogenic temperatures is a consequence of the fact that external cooling causes superficial tissue to contract more than deep tissue (thermal conductivity is low). Dr. Kletetschka’s approach is based on the idea that if a cryonics patient were perfused with a solution containing gadolinium (nanoparticles would be best), an entire vitrified brain could be cooled uniformly by the magnetocaloric effect.

From a practical point of view, his sample size was apparently very small, and he did his testing on ice rather than vitrified tissue. I had many other criticisms of his approach, which I attempted to discuss with him in a constructive, supportive manner. He was interested in what I had to say, and was very receptive. Insofar as he is so enthusiastic about doing cryonics-related research, and insofar as he lives in Maryland (not so far from Michigan) I suggested that he attend the CI Annual General Meeting on Sunday, September 27. He expressed an interest in doing so.

A European student told me that his mother is a stroke victim, but that he has not been able to induce her to consider cryonics. Having experienced the debilitating effects of stroke she is worried that faulty reanimation procedures would bring her back into an even more debilitated condition. I suggested asking her to assess the probability of that happening and how bad the downside would matter if the probability is small. I think that in the context of all of the other repairs that would be essential to cryonics working that it is unlikely that all such defects would not be fixed.

A middle-aged European woman wanted to speak with me about how to convince her husband that cryonics is a good idea. The couple are both religious, but she thinks “heaven can wait” because she enjoys life here on earth and she would like to share earthly life for a very long time with her husband. I gave her many arguments against the claim that cryonics is against religion, including the one concerning refusing a lifesaving medical treatment being equivalent to suicide (a sin).

I was reminded of the Depressed Metabolism posting about the “hostile wife phenomenon” in cryonics:  It occurs to me that when a male spouse is interested in cryonics, but his wife is not, that he can go ahead and make the arrangements. A financially dependent woman (as this woman is), less often has that option. I have also often seen cases of women interested in cryonics, but who dropped the interest when it became clear that their spouse would not join them in cryostasis. They would rather not live if they cannot be with their husbands. It reminds me of studies of working couples that show that a wife is much more likely to quit her job to follow her husband in a career change that involves moving — whereas the opposite happens much less frequently.

I won’t say much about the SENS conference itself, but I had lots of meetings and discussions that taught me a lot about biogerontology issues. I was particularly interested in discussing my recent article “Nuclear DNA Damage as a Direct Cause of Aging” which had been published in Rejuvenation Research, because it is a direct challenge to one of the tenets of SENS (that nuclear DNA damage only matters for cancer).

Not only was I able to have two private sessions in which I discussed the matter with Aubrey de Grey, but I was able to eat breakfast several times with Vera Gorbunova and her husband Andrei Seluanov, two DNA repair experts who were attending the conference. Vera and Andrei have written the only other review (other than my own) supporting the thesis that nuclear DNA repair capability declines with age.

I had cited that review in my own review. Vera had sat across from me at my first breakfast by chance. She had read my review and told me that she agreed with it. Most of the times that I went for a meal I was very pleased by at least one person randomly sitting near me, and had an interesting and productive discussion with them on a matter of interest. I discussed my cryonics alarm system problems with a woman who is getting a PhD in biomedical engineering.

I was very surprised and pleased to meet Kristen Fortney at the conference. Kristen is a University of Toronto student who attended some of our cryonics meetings in Toronto. She was a physics student and was planning to do graduate work in quantum physics. At the conference she told me she had changed to a PhD program focused on computational work with the human genome, focused on anti-aging strategies. She wrote a blog of the conference as it progressed on the Ouroboros academic blog for aging research.